Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort

Table 3 The association of MBL and different outcomes (unadjusted)

	n	Patients n = 161	P	N	Controls n = 183	P
	n	HR (95% CI)	P	N	HR (95% CI)	P
Cardiovascular events^a	70	1.03 (0.81–1.31)	0.80	29	1.3 (0.93–1.81)	0.13
Cardiovascular mortality	31	0.76 (0.52–1.13)	0.18	12	1.67 (1.06–2.64)	0.03
Total mortality	51	0.89 (0.67–1.18)	0.43	27	1.53 (1.12–2.10)	< 0.01

Increments by one standard deviation (SD) for patients (1332 μg/L) and controls (962 μg/L) from samples at discharge, respectively at baseline
Either cardiovascular mortality, nonfatal AMI, nonfatal stroke or severe heart failure
n Data are presented as number of events, HR hazard ratio, CI 95% confidence interval
^aEither cardiovascular mortality, nonfatal AMI, nonfatal stroke or severe heart failure

ISSN: 1475-2840